BRTX
NASDAQ
US
BioRestorative Therapies, Inc. - Common Stock
$0.28
▼ $-0.01
(-2.46%)
Vol 773K
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$10.4M
ROE
-233.3%
Margin
-3304.8%
D/E
0.00
Beta
0.32
52W
$1–$3
Wall Street Consensus
8 analysts · Apr 20262
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating
Price Chart
Similar Stocks
SYBX
Synlogic Inc
$13.1M
LIMN
Liminatus Pharma Inc
$16.5M
TCRT
Alaunos Therapeutics Inc
$7.2M
XBIO
Xenetic Biosciences Inc
$5.0M
CDIO
Cardio Diagnostics Holdings Inc
$4.9M
ERNA
Ernexa Therapeutics Inc
$9.4M
ENSC
Ensysce Biosciences Inc
$3.3M
QNCX
Quince Therapeutics Inc
$186.5M
MBIO
Mustang Bio Inc
$7.2M
Earnings
Beat rate: 80.0%
Next Report
May 12, 2026
EPS Estimate: $-0.30
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.30 | — | — |
| Dec 2025 | $-0.38 | $-0.31 | +$0.07 |
| Sep 2025 | $-0.37 | $-0.33 | +$0.04 |
| Jun 2025 | $-0.39 | $-0.30 | +$0.09 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -145.3% | -145.3% | -145.3% | -145.3% | -145.3% | -233.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -875.8% | -1771.9% | -1771.9% | -1771.9% | -1771.9% | -3304.8% |
| Gross Margin | 97.1% | 94.5% | 94.5% | 94.5% | 94.5% | 93.3% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 2.07 | 2.07 | 2.07 | 2.07 | 2.07 | 1.37 |
Key Ratios
ROA (TTM)
-137.9%
P/S (TTM)
27.20
P/B
1.2
EPS (TTM)
$-1.48
CF/Share
$-3.99
Rev Growth 3Y
+100.2%
52W High
$2.55
52W Low
$0.98
$0.98
52-Week Range
$2.55
How does BRTX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
BRTX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
27.2
▲
112%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
1.2
▼
53%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
BRTX profitability vs Biotechnology peers
ROE
-233.3%
▼
247%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-3304.8%
▼
1052%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
93.3%
▲
19%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-137.9%
▼
195%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
BRTX financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
1.4
▼
69%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.3
▼
67%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
BRTX fundamentals radar
BRTX
Peer median
Industry
BRTX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
BRTX vs peers: key metrics
Latest News
No related news yet